Skip to content
The People's CodeSearch
Menu

Changes to the Code

S. 5127 · Harley Jacobsen Clinical Trial Participant Income Exemption Act of 2026 ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

26 U.S.C. § 139M Clinical trial payments New section

+15 −0Shown
More for 26 U.S.C. § 139M
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Part III of subchapter B of chapter 1 of the Internal Revenue Code of 1986 is amended by inserting after section 139L the following new section:139M. Clinical trial payments (a) In general.— Gross income shall not include any amount received by an individual as a qualified clinical trial payment. (b) Qualified clinical trial payment defined.— For purposes of this section, the term qualified clinical trial payment means any amount paid to an individual— (1) as compensation for participation by the individual or a dependent of the individual in an approved clinical trial, or (2) to reimburse or pay reasonable and necessary expenses incurred in connection with participation by the individual or a dependent of the individual in an approved clinical trial. (c) Other definitions.— For purposes of this section— (1) Approved clinical trial.— The term approved clinical trial has the meaning given such term in section 2709(d)(1) of the Public Health Service Act (42 U.S.C. 300gg–8(d)(1)), determined by substituting disease or condition for life-threatening disease or condition. (2) Dependent.— The term dependent has the meaning given such term in section 152..

    The section already has a provision under this letter or number, so it would have two.

The Code already has a 26 U.S.C. § 139M, a different section added since this bill was written, so this would be a second section under that number.

§ 139M(a)–(c)

WhereMarkThe Code nowMarkAs the bill would leave it
§ 139M. [inserted: Clinical trial payments]
(a)(a) [inserted: In general.—]
[inserted: Gross income shall not include any amount received by an individual as a qualified clinical trial payment.]
(b)(b) [inserted: Qualified clinical trial payment defined.—]
[inserted: For purposes of this section, the term “qualified clinical trial payment” means any amount paid to an individual—]
(b)(1)(1) [inserted: ]
[inserted: as compensation for participation by the individual or a dependent of the individual in an approved clinical trial, or]
(b)(2)(2) [inserted: ]
[inserted: to reimburse or pay reasonable and necessary expenses incurred in connection with participation by the individual or a dependent of the individual in an approved clinical trial.]
(c)(c) [inserted: Other definitions.—]
[inserted: For purposes of this section—]
(c)(1)(1) [inserted: Approved clinical trial.—]
[inserted: The term “approved clinical trial” has the meaning given such term in section 2709(d)(1) of the Public Health Service Act (42 U.S.C. 300gg–8(d)(1)), determined by substituting “disease or condition” for “life-threatening disease or condition”.]
(c)(2)(2) [inserted: Dependent.—]
[inserted: The term “dependent” has the meaning given such term in section 152.]

Step through the changes